Uptravi 1600MCG tabs
Ended Awarded Last action
- Contract number
- 36C26019N0096
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $132,177
Award facts
- Contract value 100% obligated
- $132,176.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portland, OR 97239, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$8,681 | |
| Original award | $140,857 |
About this award
This is a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, awarded by the Department of Veterans Affairs Veterans Health Administration to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products. The $132,176.76 delivery order is for the drug Uptravi 1600MCG TABS, a treatment for pulmonary arterial hypertension. Actelion Pharmaceuticals holds a $105 million FSS contract and a $60 million Blanket Purchase Agreement to provide pulmonary hypertension medications to various VA and federal health facilities across the country. This order was issued through the Blanket Purchase Agreement mechanism and does not have a set-aside designation.
Quick answers
Who was awarded contract 36C26019N0096?
36C26019N0096 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2018.
How much is contract 36C26019N0096 worth?
The government has obligated $132,177 on 36C26019N0096.
Is contract 36C26019N0096 an order under another contract?
Yes. 36C26019N0096 is a BPA call under V797P5160B-VA797P16A0015, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26019N0096 competed?
The extent of competition for 36C26019N0096 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award